dr. verstovsek on examining cpi-0610 in myelofibrosis
Published 4 years ago • 69 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
1:45
dr. verstovsek on the manifest trial with cpi-0610 in myelofibrosis
-
2:16
dr. verstovsek on limitations of the current treatment landscape of myelofibrosis
-
1:27
bet inhibitor cpi-0610 and ruxolitinib for myelofibrosis
-
1:45
evaluating cpi-0610 as treatment of patients with myelofibrosis
-
2:08
cpi-0610: a novel bet inhibitor for mf
-
1:21
dr. verstovsek discusses immunotherapy in myelofibrosis
-
4:20
primary myelofibrosis: risk stratification
-
2:00
dr. mascarenhas on approved and emerging treatment options in myelofibrosis
-
4:24
myelofibrosis: understanding the biology and diagnosis
-
20:01
primary myelofibrosis - overview (presentation, pathophysiology, investigation, treatment)
-
22:26
what's your approach? treating myelofibrosis
-
2:35
what you should know about progression in mpns
-
6:33
fleming prize lecture 2018 introduction
-
14:54
biology2e ch15 mchen lecture video part1